欧洲疫情或二次蔓延 口罩、医疗器械板块走强
格隆汇9月22日丨欧洲疫情或二次蔓延,口罩、医疗器械等疫情相关个股全线走高。口罩股延江股份涨超10%,振德医疗、道恩股份等大涨;

医疗器械板块中,阳普医疗涨超13%,楚天科技涨超11%,英科医疗、蓝帆医疗等跟涨。

近日,欧洲多国的新冠肺炎疫情确诊人数持续增加,欧洲多国相继实施更严格社交距离限制。欧洲多国可能将会因二次疫情的暴发,再次采取严格防控措施。
有消息指出,英国首相约翰逊正考虑再次封锁,可能在英格兰采取为期两周的“迷你封锁”,以阻止近期病例的激增。世卫组织欧洲区域主任Hans Kluge近日表示,过去两周超过一半的欧洲国家病例数增长10%以上,尽管很可能是因为检测范围扩大,但也显示出欧洲地区惊人的病毒传播率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.